Anidrase carbónica
A anidrase carbônica é uma enzima que catalisa a conversão reversível de dióxido de carbono e água em bicarbonato e prótons. Esta enzima desempenha um papel crucial na manutenção do equilíbrio ácido-base, respiração e transporte de dióxido de carbono no sangue. Inibidores da anidrase carbônica são usados no tratamento de glaucoma, epilepsia e mal da altitude, bem como em pesquisas sobre homeostase ácido-base e troca gasosa. Na CymitQuimica, oferecemos uma gama de inibidores e reagentes de anidrase carbônica de alta qualidade para apoiar sua pesquisa em enzimologia, fisiologia respiratória e desenvolvimento terapêutico.
Foram encontrados 197 produtos de "Anidrase carbónica"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
EMAC10101d
CAS:compound EMAC10101d, bearing a 2,4-dichorophenyl substituent in position 4 of the dihydrothiazole ring, was the most potent and selective toward hCA II with anFórmula:C17H15Cl2N3O2S2Pureza:99.96%Cor e Forma:SolidPeso molecular:428.36Dimethylfraxetin
CAS:Dimethylfraxetin (6,7,8-Trimethoxycoumarin) is a Carbonic anhydrase inhibitor(Ki：0.0097 μM)Fórmula:C12H12O5Pureza:99.96% - ≥95%Cor e Forma:SolidPeso molecular:236.22Trichlormethiazide sodium
CAS:Trichlormethiazide sodium: oral thiazide diuretic, antihypertensive, boosts urine, Na/K excretion, may enhance renal clearance.Fórmula:C8H8Cl3N3NaO4S2Cor e Forma:SolidPeso molecular:403.63Clofenamide
CAS:Clofenamide is a low-ceiling sulfonamide diuretic.Fórmula:C6H7ClN2O4S2Cor e Forma:SolidPeso molecular:270.71hCAII-IN-2
CAS:hCAII-IN-2 inhibits human carbonic anhydrases I, II, IX, XII with Ki values of 261.4, 3.8, 19.6, 45.2 nM respectively.Fórmula:C25H18ClN5O4SCor e Forma:SolidPeso molecular:519.96hCAIX/XII-IN-3
CAS:Compound 6q inhibits hCAIX/CAXII; K i : hCAI >10000 nM, hCAII >10000 nM, hCAIX 66.2 nM, hCAXII 4.4 nM.Fórmula:C20H13F3N2O4Cor e Forma:SolidPeso molecular:402.32hCAIX-IN-8
CAS:hCAIX-IN-8, a selective hCAIX inhibitor, IC50: 0.024 μM. Also affects CAII, CAVA (IC50s: 1.99, 1.10 μM), limits cell migration, and induces apoptosis.Fórmula:C19H16N4O6Cor e Forma:SolidPeso molecular:396.35hCAXII-IN-2
CAS:hCAXII-IN-2 is a potent inhibitor of hCA XII (Ki: 84.2 nM) and hCA IX (Ki: 268.5 nM), with low activity on hCA I/II.Fórmula:C21H18ClN3O4Cor e Forma:SolidPeso molecular:411.84CDK2-IN-11
CAS:CDK2-IN-11 inhibits CDK2 (IC50: 6.4 μM) and targets hCA II, IX, XII (Ki: 23.4-56.3 nM); suited for cancer research.Fórmula:C18H14ClN7O2SCor e Forma:SolidPeso molecular:427.87hCA I-IN-2
CAS:hCA I-IN-2 (6d) inhibits hCA I (Ki: 18.8 nM) more selectively over II, IX, XII (Ki: 375.1, 1721, 283.9 nM).Fórmula:C26H20BrN5O3SCor e Forma:SolidPeso molecular:562.44FC11409B
CAS:FC11409B is a CAIX inhibitor, inhibiting breast cancer invasion and metastasis.Fórmula:C29H23BF4N2O3SCor e Forma:SolidPeso molecular:566.38hCA I-IN-1
CAS:hCA I-IN-1 inhibits hCA I (Ki: 38.3 nM), II (Ki: 716.4 nM), IX (Ki: 940.1 nM), XII (Ki: 192.8 nM).Fórmula:C27H23N5O4SCor e Forma:SolidPeso molecular:513.57hCAXII-IN-3
CAS:hCAXII-IN-3 (Compound 6o) is a selective inhibitor of human carbonic anhydrase XII (hCAXII) (Ki: 10.0 nM).Fórmula:C26H20BrN5O3SCor e Forma:SolidPeso molecular:562.44L-693612
CAS:L-693612 is an inhibitor of carbonic anhydrase.Fórmula:C14H24N2O5S3Pureza:98%Cor e Forma:SolidPeso molecular:396.55hCAI/II-IN-4
CAS:hCAI/II-IN-4 inhibits hCA I & II (Ki: 16.95 & 15.22 nM), hCA IX (Ki: 27.04 nM), has anti-hypoxia benefits and is low-toxic for AMS research.Fórmula:C15H15N3O5S2Cor e Forma:SolidPeso molecular:381.43GV2-20
CAS:GV2-20 is an effective carbonic anhydrase 2 inhibitors.Fórmula:C15H13N3O6Pureza:98%Cor e Forma:SolidPeso molecular:331.28Carbonic anhydrase inhibitor 14
CAS:CA inhibitor 14 blocks hCA I/II/IX/XII (K i of 1203/99.7/9.4/27.7 nM) and CDK2 (IC50: 20.3 μM), showing antitumor effects.Fórmula:C18H17N7O2SCor e Forma:SolidPeso molecular:395.44hCAXII-IN-5
CAS:hCAXII-IN-5, or compound 6o, is a potent, selective hCAXII inhibitor with Ki values: hCAI & II >10000, hCAIX 286.1, hCAXII 1.0 nM.Fórmula:C23H22N2O4Cor e Forma:SolidPeso molecular:390.43Methazolamide-d6
CAS:Methazolamide-d6 is a GC/LC-MS standard for measuring methazolamide, a glaucoma drug that lowers eye pressure and fluid, reduces seizures, and combats ROS.Fórmula:C5H2D6N4O3S2Cor e Forma:SolidPeso molecular:242.31L 645151
CAS:L 645151 is an inhibitor of lipophilic CA.Fórmula:C12H14N2O4S2Cor e Forma:SolidPeso molecular:314.38Disulfamide
CAS:Disulfamide: Oral carbonic anhydrase inhibitor, IC50 0.07 μM, diuretic by blocking Na+/HCO3- reabsorption.Fórmula:C7H9ClN2O4S2Pureza:98.65%Cor e Forma:SolidPeso molecular:284.74AHR-15010
CAS:AHR-15010 is a novel anti-arthritic agent.Fórmula:C10H16N2O8S2Pureza:98%Cor e Forma:SolidPeso molecular:356.37L-693612 HCl
CAS:L-693612 HCl is an inhibitor of carbonic anhydrase.Fórmula:C14H25ClN2O5S3Pureza:98%Cor e Forma:SolidPeso molecular:433.01hCAIX-IN-5
CAS:hCAIX-IN-5 was a selective hCAIX inhibitor, inhibiting hCAI, hCAII, hCAIV, and hCAIX with Ki values of >10000, >10000, 130.7, and 829.1 nM, respectively.Fórmula:C18H12FNO3Pureza:99.25%Cor e Forma:SolidPeso molecular:309.29hCAIX-IN-7
CAS:hCAIX-IN-7 (6c) selectively inhibits tumor-related isoform hCAIX (KI: 410.6 nM) and weakly affects hCAI/II (KI: >10000 nM).Fórmula:C18H12FNO3Cor e Forma:SolidPeso molecular:309.29Carbonic anhydrase inhibitor 13
CAS:Carbonic anhydrase inhibitor 13 (compound 7) is a potent inhibitor of carbonic anhydrase (CA).Fórmula:C17H15N5O3S2Cor e Forma:SolidPeso molecular:401.46WES-1
CAS:WES-1 (Compound 8g), a carbonic anhydrase IX inhibitor (Ki: 55.9 μM), exhibits broad-spectrum antiproliferative activity against various cancer cell lines,Fórmula:C20H20N4O3SPureza:98%Cor e Forma:SolidPeso molecular:396.46hCAIX-IN-3
CAS:hCAII-IN-3 (7e) selectively inhibits CA II/IX with Kis of 124.2/30.5 nM, showing promise for cancer treatment.Fórmula:C21H21BrN6O4SCor e Forma:SolidPeso molecular:533.4hCAIX-IN-14
CAS:hCAIX-IN-14 is a potent inhibitor of human CA IX with a K i value of 134.8 nM .Fórmula:C11H17ClN6O2SCor e Forma:SolidPeso molecular:332.81Carbonic anhydrase inhibitor 7
CAS:Potent hCA inhibitor; targets hCA IX, II, XII, I with Ki: 6.5, 7.1, 72.1, 255.8 nM respectively.Fórmula:C23H17N3O5SCor e Forma:SolidPeso molecular:447.46hCAXII-IN-1
CAS:hCAXII-IN-1 selectively inhibits HCA IX/XII, promising for new cancer drug development.Fórmula:C20H17NO5Cor e Forma:SolidPeso molecular:351.35Quinethazone
CAS:Quinethazone is a thiazide diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.Fórmula:C10H12ClN3O3SCor e Forma:Fibrous Crystals From 50% Acetone Physical Description Fibrous Crystals Or White Powder (Ntp 1992)Peso molecular:289.74hCAIX-IN-10
CAS:"hCAIX-IN-10 (6i) selectively inhibits carbonic anhydrase IX/XII (Ki: 61.5/586.8 nM), markers in tumor cells, affecting acid-base balance."Fórmula:C28H21N3O3SCor e Forma:SolidPeso molecular:479.55hCAIX-IN-6
CAS:6B and 14g inhibit tumor-associated HCA IX with low nanomolar potency; 6K targets HCA XII. All are potential cancer drug leads.Fórmula:C18H12N2O4SCor e Forma:SolidPeso molecular:352.36DTP348
CAS:DTP348: Oral carbonic anhydrase IX inhibitor & hypoxic cell radiosensitizer with sulfamide & 5-nitroimidazole components.Fórmula:C6H11N5O4SCor e Forma:SolidPeso molecular:249.25Carbonic anhydrase inhibitor 11
CAS:Potent carbonic anhydrase inhibitor VI targets CA II, IX, XII with Ki: 40, 39, 900 nM respectively.Fórmula:C19H15F3N4O3S2Cor e Forma:SolidPeso molecular:468.47hCAIX/XII-IN-4
CAS:hCAIX/XII-IN-4 inhibits CAIX/XII with Ki: 4.5 nM (CAXII), 23.6 nM (CAIX), and >10000 nM (CAI/CAII).Fórmula:C20H16N2O5Cor e Forma:SolidPeso molecular:364.35HCAIX-IN-2
CAS:HCAIX-IN-2 (compound 9d) is a selective inhibitor of carbonic anhydrase and acts on hCA IX (Ki: 24.6 nM) and hCA XII (Ki: 45.3 nM).Fórmula:C19H16N8O4SCor e Forma:SolidPeso molecular:452.45hCAXII-IN-4
CAS:hCAXII-IN-4 is a selective and potent CA XII inhibitor with a Ki value of 6.4 nM for human CA XII.Fórmula:C22H27N5O6SCor e Forma:SolidPeso molecular:489.54hCAIX-IN-11
CAS:hCAIX-IN-11 inhibits carbonic anhydrases IX & XII with Ki of 32.7 nM & 623.5 nM, respectively.Fórmula:C21H15ClN4O3Cor e Forma:SolidPeso molecular:406.82L 662583
CAS:L 662583 is a topical inhibitor of carbonic anhydrase.Fórmula:C13H17ClN2O5S3Pureza:98%Cor e Forma:SolidPeso molecular:412.93hCAI/II-IN-2
CAS:hCAI/II-IN-2 (2b) inhibits hCA I/II (Ki: 40.97 nM, 15.15 nM) and IX (61.88 nM), fights AMS with anti-hypoxic effects, but has low cellular activity.Fórmula:C12H12N4O5S2Cor e Forma:SolidPeso molecular:356.38hCA IX-IN-2
hCA IX-IN-2 is a highly potent and selective inhibitor of hCA IX, exhibiting an inhibition constant (K I) value of 32.1 nM and demonstrating anti-proliferativeFórmula:C23H24N2O4STeCor e Forma:SolidPeso molecular:552.11hCAI/II-IN-1
CAS:hCAI/II-IN-1 (Compound 3h) is a human carbonic anhydrase I and II (hCA I/II) inhibitor that acts on hCA I (IC50: 0.047 μM) and hCA II (IC50: 0.024 μM).Fórmula:C18H29N5O3S3Cor e Forma:SolidPeso molecular:459.65hCAI/II-IN-3
CAS:"hCAI/II-IN-3 (compound 5b) is a potent dual hCA I/II inhibitor with Ki: 51.25nM (I), 13.15nM (II), helps treat AMS."Fórmula:C16H18N4O4S2Cor e Forma:SolidPeso molecular:394.47hCAIX/XII-IN-6
hCAIX/XII-IN-6: Oral carbonic anhydrase inhibitor, targets hCA I/II/IV/IX/XII, aids rheumatoid arthritis research. Ki: 6697/2950/4093/4.1/7.7 nM.Fórmula:C26H23N3O6S4Cor e Forma:SolidPeso molecular:601.74hCAII-IN-1
CAS:hCAII-IN-1 (7f) inhibits CA II/IX with Kis 1.2 nM/113.6 nM, potential for cancer treatment.Fórmula:C21H21BrN6O4SCor e Forma:SolidPeso molecular:533.4hCAIX/XII-IN-2
CAS:Compound 6a: Selective hCAIX/XII inhibitor; Ki: 30 nM (hCAIX), 3.6 nM (hCAXII); >10,000 nM (hCAI/II).Fórmula:C19H14N2O4Cor e Forma:SolidPeso molecular:334.33CDK2-IN-12
CAS:CDK2-IN-12 (10b), potent CDK2 inhibitor, IC50: 11.6 μM; inhibits hCA I/II/IX/XII, KI: 3534/638.4/44.3/48.8 nM; anti-cancer properties.Fórmula:C20H17N9O2SCor e Forma:SolidPeso molecular:447.47hCAII-IN-9
CAS:hCAII-IN-9 inhibits hCA II/IX/XII with IC50s of 1.18, 0.17, 2.99 μM; not BBB permeable.
Fórmula:C15H16ClN3O5S2Pureza:98.63%Cor e Forma:SolidPeso molecular:417.89hCAI/II-IN-6
CAS:hCAI/II-IN-6 is a selective and orally active inhibitor of human carbonic anhydrase (CA).Fórmula:C19H24N4O3SPureza:98.49%Cor e Forma:SolidPeso molecular:388.48Sultiame
CAS:Sultiame is an inhibitor of carbonic anhydrase. Sultiame can be used in antiepileptic research.Fórmula:C10H14N2O4S2Pureza:99.91%Cor e Forma:SolidPeso molecular:290.36Carbonic anhydrase inhibitor 6
CAS:Carbonic anhydrase inhibitor 6 is an hCA inhibitor that inhibits hCA IX, hCA II, hCA XII, and hCA I. It is used in the study of lupus erythematosus.Fórmula:C26H25N3O5SPureza:98.81%Cor e Forma:SolidPeso molecular:491.56Ref: TM-T63305
1mg164,00€2mg234,00€5mg389,00€10mg532,00€25mg820,00€50mg1.063,00€100mg1.350,00€200mg1.783,00€Carbonic anhydrase inhibitor 12
CAS:CA Inhibitor 12 strongly blocks CA II (K_i 1.72 nM), also inhibits CA I (271 nM), shows anticancer effects.Fórmula:C27H22BrN5O5S2Pureza:98%Cor e Forma:SolidPeso molecular:640.53hCAIX-IN-16
CAS:hCAIX-IN-16 (Compound 12d), an inhibitor of hCA IX, exhibits inhibition constants (K i) of 190.0 nM for hCA IX and 187.9 nM for hCA XII.Fórmula:C20H20N8O2SPureza:98%Cor e Forma:SolidPeso molecular:436.49COX-2-IN-30
CAS:COX-2-IN-30, a benzenesulfonamide derivative, is an orally active, dual inhibitor of cyclooxygenase-2 (COX-2; IC50 = 49 nM) and cyclooxygenase-1 (COX-1; IC50 =Fórmula:C17H16N6O3SPureza:98%Cor e Forma:SolidPeso molecular:384.41CAXII-IN-1
CAS:CAXII-IN-1, antitumor, selectively inhibits CA XII with Ki of 3.8 nM for hCA XII and 56 nM for hCA IX.Fórmula:C13H7Cl2NO3SCor e Forma:SolidPeso molecular:328.17N-Desethyl Brinzolamide oxalate
CAS:N-Desethyl Brinzolamide oxalate functions as a dual inhibitor targeting Carbonic anhydrase II and Carbonic anhydrase IV, exhibiting inhibitory concentrations (IC50) of 1.28 nM and 128 nM, respectively [1].Fórmula:C12H19N3O9S3Cor e Forma:SolidPeso molecular:445.49hCAIX-IN-15
CAS:hCAIX-IN-15 is a potent inhibitor of human carbonic anhydrase IX (hCA IX) with an inhibition constant (Ki) of 38.8 nM, exhibiting broad-spectrum anticancerFórmula:C18H14FN7O2SPureza:98%Cor e Forma:SolidPeso molecular:411.41hCAIX/XII-IN-8
CAS:hCAIX/XII-IN-8 (compound 3g) is a potent inhibitor of the human carbonic anhydrases (CAs) IX and XII, with inhibition constants (K i) of 8.5 nM for CA IX and 6.Fórmula:C16H13Cl2N5O3SPureza:98%Cor e Forma:SolidPeso molecular:426.28Sezolamide hydrochloride
CAS:Sezolamide hydrochloride is a potent topical carbonic anhydrase inhibitor.Fórmula:C11H19ClN2O4S3Cor e Forma:SolidPeso molecular:374.93ALP/Carbonic anhydrase-IN-1
CAS:Compound 1e, also known as ALP/Carbonic anhydrase-IN-1, is a dual inhibitor targeting both carbonic anhydrase (CA) isozymes II, IX, and XII, as well as alkalineFórmula:C15H16N2Pureza:98%Cor e Forma:SolidPeso molecular:224.3Sezolamide
CAS:Sezolamide is a carbonic anhydrase inhibitor.Fórmula:C11H18N2O4S3Cor e Forma:SolidPeso molecular:338.47hCA XII/II/IX-IN-1
hCA XII/II/IX-IN-1 inhibits hCA I/II/IX/XII (IC50: 2.6, 0.004, 0.005, 0.001 μM) with anticancer properties.Fórmula:C25H34N4O7SCor e Forma:SolidPeso molecular:534.63Carbonic anhydrase inhibitor 10
CA inhibitor 10 targets MCF-7 cells, IC50: 11.9 μM; potent h CA IX inhibitor, Ki: 6.2 nM. Anti-cancer research.Fórmula:C14H17N5O3SCor e Forma:SolidPeso molecular:335.38β-Glucuronidase/hCAII-IN-1
CAS:β-Glucuronidase/hCAII-IN-2 (Compound 12e) is a compound that effectively inhibits both β-glucuronidase and human Carbonic Anhydrase II (hCA II), exhibiting IC50Fórmula:C30H21NO9Cor e Forma:SolidPeso molecular:539.49NSC 828467
NSC 828467 is one of the top five CA-IX inhibitors with significant in vitro anticancer activity (IC50: 27.2 nM).Fórmula:C21H19N9O2SCor e Forma:SolidPeso molecular:461.5hCA VB-IN-1
hCA VB-IN-1 (compound 15) is a potent and selective inhibitor of hCA VB (carbonic anhydrase) with a KI of 515.7 nM [1].Fórmula:C9H13N3O4SCor e Forma:SolidPeso molecular:259.28CAII-IN-2
CAII-IN-2 (3g): potent, selective CA-II inhibitor; IC50-12.1 μM for bovine CA-II; valuable in CA-related disorder research.Fórmula:C18H19BrN4SCor e Forma:SolidPeso molecular:403.34Carbonic anhydrase inhibitor 5
Potent hCA inhibitor: targets hCA II, IX & XII with IC50s of 42.9, 47.6, & 6.7 nM respectively.Fórmula:C24H20ClN3O3SCor e Forma:SolidPeso molecular:465.95Carbonic anhydrase inhibitor 9
Carbonic anhydrase inhibitor 9 targets hCA II and IX with Ki of 56.4 and 56.9 nM respectively; shows antiproliferative activity.Fórmula:C22H20BrN5O4SCor e Forma:SolidPeso molecular:530.39hCAII-IN-5
CAS:hCAII-IN-5 (compound 12h) is a potent, selective inhibitor of human carbonic anhydrase II (hCA II) with an inhibition constant (IC50) of 4.55 µM [1].Fórmula:C29H18N2O7Cor e Forma:SolidPeso molecular:506.46hCAII-IN-3
hCAII-IN-3 inhibits key hCA isoforms with Ki: hCA I (403.8 nM), hCA II (5.1 nM), hCA IX (10.2 nM), hCA XII (5.2 nM); shows anticancer potential.Fórmula:C17H21N3O3SCor e Forma:SolidPeso molecular:347.43Perfluorohexane sulfonamide
CAS:Perfluorohexane sulfonamide (FHxSA) serves as an inhibitor of carbonic anhydrase (CA), effectively inhibiting bovine CA and human CAII with IC50 values of 0.122 and 1.38 μM, respectively. Additionally, it acts as a delayed-action insecticide for controlling red imported fire ants (Solenopsis invicta). Furthermore, Perfluorohexane sulfonamide is considered a potential environmental pollutant.Fórmula:C6H2F13NO2SCor e Forma:SolidPeso molecular:399.13hCAIX/XII-IN-15
CAS:hCAIX/XII-IN-15 (Compound 17β) is an inhibitor of hCA IX and hCA XII, exhibiting Ki values of 0.42 and 4.37 μM, respectively. It demonstrates a pro-apoptotic effect in multiple myeloma cells.Fórmula:C17H18O4SCor e Forma:SolidPeso molecular:318.387Carbonic anhydrase inhibitor 4
CA inhibitor 4, photoprobe; targets hCA I-XIV; Ki: 640-1166 nM.Fórmula:C21H18N2O4SCor e Forma:SolidPeso molecular:394.44CA IX-IN-1
CA IX-IN-1 (compound 12g) is a potent and highly selective hCA IX inhibitor (IC50: 7 nM) that exhibits antitumour effects.Fórmula:C16H22N4O8SCor e Forma:SolidPeso molecular:430.43hCAI/II/XII-IN-1
CAS:hCAI/II/XII-IN-1 (compound 7) is an inhibitor of human carbonic anhydrases hCAI, hCAII, and hCAXII, with Ki values of 78.5 nM, 9.1 nM, 605 nM, 7.7 nM, and 3.7 nM.Fórmula:C12H12N2O2SCor e Forma:SolidPeso molecular:248.301CA IX-IN-3
CAS:CAIX-IN-3 (Compound 27) is a selective and potent inhibitor of carbonic anhydrase IX (CAIX), with an IC50 of 0.48 nM.Fórmula:C21H19N5O4S2Cor e Forma:SolidPeso molecular:469.537CAII-IN-1
CAII-IN-1 (3n) is a selective bovine CA-II inhibitor with 10.3 μM IC50, used in carbonic anhydrase disorder studies.Fórmula:C19H21FN4SCor e Forma:SolidPeso molecular:356.46hCAVII/IX-IN-1
CAS:hCAVII/IX-IN-1 (compound 4) functions as an inhibitor of hCAVII/IX, exhibiting Ki values of 56.5 nM and 38.2 nM, respectively. It is applicable in the field of cancer research.Fórmula:C7H7N3O2S2Cor e Forma:SolidPeso molecular:229.279CAII-IN-3
CAII-IN-3, a thiosemicarbazone, potently inhibits CA-II with an IC50 of 13.4 μM.Fórmula:C18H18F2N4SCor e Forma:SolidPeso molecular:360.42β-Glucuronidase/hCAII-IN-2
β-Glucuronidase/hCAII-IN-2 is a potent inhibitor of β-glucuronidase and hCA II, and their IC50 values were 670.7 μM and 21.77 μM, respectively.Fórmula:C31H23NO8Cor e Forma:SolidPeso molecular:537.52Carbonic anhydrase inhibitor 2
CAS:Compound 7c inhibits carbonic anhydrase II, lowering intraocular pressure in glaucomatous rabbits.Fórmula:C12H16N4O6SCor e Forma:SolidPeso molecular:344.34hCAII-IN-4
CAS:hCAII-IN-4 (Compound 12j) is a potent inhibitor of human carbonic anhydrase II (hCA II), exhibiting an inhibitory concentration (IC50) of 7.78 μM.Fórmula:C31H23NO9Cor e Forma:SolidPeso molecular:553.52Carbonic anhydrase inhibitor 3
Carbonic anhydrase inhibitor 3 (compound 11g) is an inhibitor of carbonic anhydrase II that reduces the intraocular pressure in glaucomatous rabbits [1].Fórmula:C15H17N3O3SCor e Forma:SolidPeso molecular:319.38Valerate sodium
CAS:Valerate sodium is a potential Carbonic anhydrase 1/2 inhibitor for biochemical experiments.Fórmula:C5H9NaO2Pureza:99.84% - 99.91%Cor e Forma:SolidPeso molecular:124.11Carbonic anhydrase inhibitor 16
CAS:Carbonic anhydrase inhibitor 16 (compound 1) is a CA I/CA II inhibitor with potential antiviral activity, used in virus infection studies.Fórmula:C14H10N2O4SPureza:99.65%Cor e Forma:SolidPeso molecular:302.31hCAIX-IN-20
CAS:hCAIX-IN-20 (compound APBS-5m) is a potent inhibitor of carbonic anhydrase IX (hCA IX), with a Ki of 2.7 nM, playing a significant role in cancer research.Fórmula:C19H13Cl2N5O4S2Peso molecular:510.37Carbonic anhydrase inhibitor 17
CAS:Carbonic anhydrase inhibitor 17 (compound 7c) is a pyrazine-based sulfonamide that acts as a carbonic anhydrase II inhibitor, with an IC50 value of 0.63 nM.Fórmula:C18H15ClN4O3S2Peso molecular:434.92Carbonic anhydrase inhibitor 19
CAS:Carbonic anhydrase inhibitor19 (compound 26a) targets glaucoma-associated isozymes hCA II and hCA XII, with inhibition constants (Kis) of 9.4 nM and 6.7 nM, respectively. This compound is effective in reducing intraocular pressure.Fórmula:C23H25N3O6S2Peso molecular:503.59EGFR/VEGFR2-IN-2
EGFR/VEGFR2-IN-2 (compound 4b) serves as a dual inhibitor of VEGFR-2 and EGFR.Fórmula:C24H15FO3Cor e Forma:SolidPeso molecular:370.37α-Glucosidase-IN-63
CAS:α-Glucosidase-IN-63 (Compound 4d) serves as an α-Glucosidase inhibitor with an IC 50 value of 0.44 μM. Additionally, it exhibits inhibitory activity against hCA II, demonstrating a K i of 7.0 nM. The compound is also effective when administered orally. [1]Fórmula:C16H12FN3O3S2Cor e Forma:SolidPeso molecular:377.41Sulclamide
CAS:Sulclamide, a sulfamoylbenzoic acid derivative, exhibits diuretic activity and functions as an inhibitor of carbonic anhydrase [1].Fórmula:C7H7ClN2O3SCor e Forma:SolidPeso molecular:234.664-Acetylphenylboronic acid
CAS:4-Acetylphenylboronic acid acts as an effective inhibitor targeting carbonic anhydrase II (CAII), displaying inhibitory concentrations (IC50) of 246 μM for bovine CAII (bCA II) and 281.40 μM for human CAII (hCA II).Fórmula:C8H9BO3Cor e Forma:SolidPeso molecular:163.97O-Desmethyl Brinzolamide hydrochloride
CAS:O-Desmethyl Brinzolamide hydrochloride (compound 6a), a potent metabolite derived from Brinzolamide, serves as a carbonic anhydrase (CA) inhibitor. It exhibits a dissociation constant (Kd) of 0.136 nM for CA II and an inhibitory concentration (IC50) of 165 nM for CA IV [1].Fórmula:C11H20ClN3O5S3Cor e Forma:SolidPeso molecular:405.94Carbonic anhydrase inhibitor 8
R-13, a carbonic anhydrase inhibitor, has Ki of 60.7 nM (hCA I), 320.7 nM (hCA II), and 2298 nM (hCA IV).Fórmula:C20H25N3O4SCor e Forma:SolidPeso molecular:403.5
